First Manhattan’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,396
| Closed | -$194K | – | 834 |
|
|
2024
Q1 | $194K | Sell |
1,396
-380
| -21% | -$52.7K | ﹤0.01% | 662 |
|
|
2023
Q4 | $220K | Buy |
1,776
+126
| +8% | +$15.6K | ﹤0.01% | 633 |
|
|
2023
Q3 | $154K | Buy |
1,650
+3
| +0.2% | +$280 | ﹤0.01% | 695 |
|
|
2023
Q2 | $212K | Buy |
1,647
+107
| +7% | +$13.8K | ﹤0.01% | 653 |
|
|
2023
Q1 | $179K | Buy |
1,540
+380
| +33% | +$44.1K | ﹤0.01% | 698 |
|
|
2022
Q4 | $131K | Buy |
1,160
+760
| +190% | +$86.1K | ﹤0.01% | 782 |
|
|
2022
Q3 | $32K | Hold |
400
| – | – | ﹤0.01% | 1003 |
|
|
2022
Q2 | $29K | Hold |
400
| – | – | ﹤0.01% | 1060 |
|
|
2022
Q1 | $51K | Hold |
400
| – | – | ﹤0.01% | 1000 |
|
|
2021
Q4 | $53K | Hold |
400
| – | – | ﹤0.01% | 983 |
|
|
2021
Q3 | $54K | Hold |
400
| – | – | ﹤0.01% | 978 |
|
|
2021
Q2 | $42K | Hold |
400
| – | – | ﹤0.01% | 1017 |
|
|
2021
Q1 | $35K | Buy |
400
+200
| +100% | +$17.5K | ﹤0.01% | 1030 |
|
|
2020
Q4 | $18K | Hold |
200
| – | – | ﹤0.01% | 1067 |
|
|
2020
Q3 | $20K | Sell |
200
-172
| -46% | -$17.2K | ﹤0.01% | 1022 |
|
|
2020
Q2 | $37K | Buy |
372
+200
| +116% | +$19.9K | ﹤0.01% | 928 |
|
|
2020
Q1 | $11K | Buy |
+172
| New | +$11K | ﹤0.01% | 1120 |
|
|
2018
Q1 | – | Sell |
-15,596
| Closed | -$223K | – | 1397 |
|
|
2017
Q4 | $223K | Buy |
+15,596
| New | +$223K | ﹤0.01% | 695 |
|